{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:41:02Z","timestamp":1793353262307,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/idoj.idoj_237_21","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T02:28:31Z","timestamp":1642991311000},"page":"64","source":"Crossref","is-referenced-by-count":4,"title":["Proton pump inhibitor induced subacute cutaneous lupus erythematosus: A case series of 7 patients and brief review of literature"],"prefix":"10.4103","volume":"13","author":[{"given":"Palvi","family":"Singla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.336352-1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute cutaneous lupus erythematosus: A cutaneous marker for a distinct lupus erythematosus subset","author":"Sontheimer","year":"1979","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.336352-2","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.336352-3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/2229-5178.336352-4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","article-title":"Drug-induced lupus: An update on its dermatologic aspects","author":"Marzano","year":"2009","journal-title":"Lupus"},{"key":"key-10.4103\/2229-5178.336352-5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2133.2011.10397.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: Evidence for differences from its idiopathic counterpart","author":"Marzano","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.336352-6","first-page":"227","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: A population-based matched case-control study of 234 patients in Sweden","author":"Gronhagen","year":"2012","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.336352-7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjd.12699","article-title":"Proton pump inhibitor-induced subacute cutaneous lupus erythematosus","author":"Sandholdt","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.336352-8","first-page":"28","article-title":"Drug-induced cutaneous lupus erythematosus: 88 new cases","author":"Laurinaviciene","year":"2017","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/2229-5178.336352-9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40801-016-0067-4","article-title":"Drug induced subacute cutaneous lupus erythematosus associated with proton pump inhibitors","author":"Aggarwal","year":"2016","journal-title":"Drugs- Real World Outcomes"},{"key":"key-10.4103\/2229-5178.336352-10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ACI.0b013e328355b8d3","article-title":"Hypersensitivity reactions to proton pump inhibitors","author":"Chang","year":"2012","journal-title":"Curr Opin Allergy Immunol"},{"key":"key-10.4103\/2229-5178.336352-11","first-page":"353","article-title":"Lansoprazole induced subacute cutaneous lupus erythematosus: Two cases","author":"Bracke","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/2229-5178.336352-12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2340\/00015555-0335","article-title":"Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors","author":"Dam","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/2229-5178.336352-13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2340\/00015555-0473","article-title":"Clinical follow-up of 102 anti-Ro\/SSA-positive patients with dermatological manifestations","author":"Popovic","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/2229-5178.336352-14","first-page":"731","article-title":"Lansoprazole-induced subacute cutaneous lupus erythematosus","author":"Panting","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.336352-15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2230.2008.03125.x","article-title":"Omeprazole-induced subacute cutaneous lupus erythematosus","author":"Mankia","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.336352-16","first-page":"860","article-title":"Anti-Ro and anti-la antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole","author":"McCourt","year":"2010","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/2229-5178.336352-17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2230.2010.03926.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole","author":"Toms-Whittle","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.336352-18","first-page":"640","article-title":"Esomeprazole-induced subacute cutaneous lupus erythematosus","author":"Alc\u00e1ntara-Gonz\u00e1lez","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"key-10.4103\/2229-5178.336352-19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5114\/aoms.2012.30300","article-title":"Subacute cutaneous lupus erythematosus due to proton pump inhibitor intake: Case report and literature review","author":"Reich","year":"2012","journal-title":"Arch Med Sci"},{"key":"key-10.4103\/2229-5178.336352-20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2230.2011.04245.x","article-title":"A difficult diagnosis: Drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE","author":"Wee","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.336352-21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000346694","article-title":"Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors","author":"Almebayadh","year":"2013","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.336352-22","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.2015.9391","article-title":"Widespread scaly eruption in a patient with multiple comorbidities","author":"Jones","year":"2015","journal-title":"JAMA"},{"key":"key-10.4103\/2229-5178.336352-23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/ced.12592","article-title":"Proton pump inhibitor-induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus","author":"Hung","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.336352-24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00228-015-1840-0","article-title":"Subacute cutaneous lupus erythematosus induced by lansoprazole","author":"Drago","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/2229-5178.336352-25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5606\/ArchRheumatol.2017.6237","article-title":"Lansoprazole-induced subacute cutaneous lupus erythematosus","author":"An","year":"2017","journal-title":"Arch Rheumatol"},{"key":"key-10.4103\/2229-5178.336352-26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamadermatol.2020.2415","article-title":"Omeprazole induced subacute cutaneous lupus erythematosus","author":"Hall","year":"2020","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/2229-5178.336352-27","doi-asserted-by":"crossref","unstructured":"Michaelis TC, Sontheimer RD, Lowe GC. An update in drug-induced subacute cutaneous lupus erythematosus. Dermatol Online J 2017;23. doi: 10.5070\/D3233034281.","DOI":"10.5070\/D3233034281"},{"key":"key-10.4103\/2229-5178.336352-28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00403-008-0890-x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: A paradigm for bedside-to-bench patient-oriented translational clinical investigation","author":"Sontheimer","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"key-10.4103\/2229-5178.336352-29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/2229-5178.336352-30","first-page":"132","article-title":"Drug-induced lupus erythematosus associated with proton pump inhibitor","author":"Chinnusamy","year":"2020","journal-title":"J Health Allied Sci NU"},{"key":"key-10.4103\/2229-5178.336352-31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0961203311426568","article-title":"Environment and lupus-related diseases","author":"Zandman-Goddard","year":"2012","journal-title":"Lupus"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:32Z","timestamp":1787163872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_237_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["336352"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_237_21","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}